Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmaco-epidemiology of anticoagulant treatment in symptomatic pulmonary embolism in elderly patients
2013-000315-24Phase 4Active
- Sponsor
- CHU Saint-Etienne
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of acenocoumarol in pulmonary embolism (PE) and Phlebothrombosis, sponsored by CHU Saint-Etienne. Primary endpoint: Major bleeding. Started May 2019; status: active.
02
Drugs
acenocoumarol
03
Conditions
pulmonary embolism (PE)Phlebothrombosis
Beyond the preview
Go deeper on 2013-000315-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000315-24.